- Novo Nordisk will partner with Anthropic to enhance drug development using Claude Science
- The collaboration aims to solve key drug discovery challenges and support biological reasoning
- Initial efforts focus on testing Claude Science in specific R&D workflows and scientific problems
Novo Nordisk will collaborate with Anthropic to boost the development of new medicines through Claude Science, the drugmaker said in a statement on Wednesday, September 16.
The companies seek to address key drug discovery challenges identified by scientists and computational teams at Novo, develop solutions for specific scientific problems and workflows to support biological reasoning, and help accelerate the discovery and development of new medicines.
-
Indian Markets Turning Corner After Two Tough Years, Says Sandeep Tandon -
NDTV Profit Ignite 2026: Experts See Opportunity In Equities, Stay Bullish For Long-Term -
Buy Right, Sit Tight Does Not Work for Individual Stocks, Says Dinshaw Irani -
'Worst Is Behind': Quant MF Sees Market Bottom, Flags 'Extreme Euphoria' In Midcaps -
India's Mutual Fund Industry Could Become A $1 Trillion Opportunity, Say Fund Managers -
'Foreign Investors Are Baraatis': Raamdeo Agrawal's Take On LTCG Tax -
Stay Invested Through Market Cycles: Raamdeo Agrawal at NDTV Profit Ignite -
Ramesh Damani Remains Bullish On India For Next 20-30 Years, Sees Bargains Amid Market Weakness -
CAS Came After A Long Consultation Process: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFIT IGNITE -
Aim To Cut FPI Onboarding Time From Mth To Five Days: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFI
In the initial stage, Novo will test Claude Science for specific workflows in R&D and address scientific problems where the joint capabilities of Novo and Anthropic are expected to have the greatest impact.
“Joining forces with Anthropic will supercharge our R&D organisation and help us on our mission to bring new, transformative health solutions to people living with chronic diseases,“ said Mike Doustdar, President and CEO of Novo.
“AI can help us increase productivity in R&D and compress the path from research to marketed product. But beyond this, AI tools can also offer completely new scientific opportunities and aid reasoning and understanding of human biology and drug mechanics," Doustdar added.
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.